Literature DB >> 33664169

Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols.

Ali A Rabaan1, Shamsah H Al-Ahmed2, Maysaa Al-Malkey3, Roua Alsubki4, Sayeh Ezzikouri5, Fadel Hassan Al-Hababi6, Ranjit Sah7, Abbas Al Mutair8, Saad Alhumaid9, Jaffar A Al-Tawfiq10, Awad Al-Omari11, Ayman M Al-Qaaneh12, Manaf Al-Qahtani13, Raghavendra Tirupathi14, Mohammad A Al Hamad15, Nadira A Al-Baghli16, Tarek Sulaiman17, Arwa Alsubait18, Rachana Mehta19, Elfadil Abass20, Maha Alawi21, Fatimah Alshahrani22, Dhan Bahadur Shrestha23, Mohmed Isaqali Karobari24, Samuel Pecho-Silva25, Kovy Arteaga-Livias26, D Katterine Bonilla-Aldana27, Alfonso J Rodriguez-Morales28.   

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic worldwide. On a daily basis the number of deaths associated with COVID-19 is rapidly increasing. The main transmission route of SARS-CoV-2 is through the air (airborne transmission). This review details the airborne transmission of SARS-CoV-2, the aerodynamics, and different modes of transmission (e.g. droplets, droplet nuclei, and aerosol particles). SARS-CoV-2 can be transmitted by an infected person during activities such as expiration, coughing, sneezing, and talking. During such activities and some medical procedures, aerosols and droplets contaminated with SARS-CoV-2 particles are formed. Depending on their sizes and the environmental conditions, such particles stay viable in the air for varying time periods and can cause infection in a susceptible host. Very few studies have been conducted to establish the mechanism or the aerodynamics of virus-loaded particles and droplets in causing infection. In this review we discuss the various forms in which SARS-CoV-2 virus particles can be transmitted in air and cause infections.

Entities:  

Mesh:

Year:  2021        PMID: 33664169

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  17 in total

1.  Migrant agricultural workers' deaths in Ontario from January 2020 to June 2021: a qualitative descriptive study.

Authors:  Susana Caxaj; Maxwell Tran; Stephanie Mayell; Michelle Tew; Janet McLaughlin; Shail Rawal; Leah F Vosko; Donald Cole
Journal:  Int J Equity Health       Date:  2022-07-16

Review 2.  The potential role of COVID-19 in the induction of DNA damage.

Authors:  Pablo Pánico; Patricia Ostrosky-Wegman; Ana María Salazar
Journal:  Mutat Res Rev Mutat Res       Date:  2022-01-19       Impact factor: 7.015

3.  Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia.

Authors:  Saad Alhumaid; Abbas Al Mutair; Zainab Al Alawi; Khulud Al Salman; Nourah Al Dossary; Ahmed Omar; Mossa Alismail; Ali M Al Ghazal; Mahdi Bu Jubarah; Hanan Al Shaikh; Maher M Al Mahdi; Sarah Y Alsabati; Dayas K Philip; Mohammed Y Alyousef; Abdulsatar H Al Brahim; Maitham S Al Athan; Salamah A Alomran; Hatim S Ahmed; Haifa Al-Shammari; Alyaa Elhazmi; Ali A Rabaan; Jaffar A Al-Tawfiq; Awad Al-Omari
Journal:  Eur J Med Res       Date:  2021-05-24       Impact factor: 2.175

Review 4.  The Effectiveness of the Anteroom (Vestibule) Area on Hospital Infection Control and Health Staff Safety: A Systematic Review.

Authors:  Elham Andalib; Masoumeh Faghani; Seyyed Mahdi Zia Ziabari; Mohammad Shenagari; Hamid Salehiniya; Mohammad Hossein Keivanlou; Zahra Rafat
Journal:  Front Public Health       Date:  2022-04-26

5.  Infection Risk Prediction Model for COVID-19 Based on an Analysis of the Settlement of Particles Generated during Dental Procedures in Dental Clinics.

Authors:  Paula Alejandra Baldion; Henry Oliveros Rodríguez; Camilo Alejandro Guerrero; Alberto Carlos Cruz; Diego Enrique Betancourt
Journal:  Int J Dent       Date:  2021-12-30

Review 6.  The Endocannabinoid System as Prognostic Biomarker of the Obstructive Sleep Apnea Morbidity in COVID-19-Recovered Individuals.

Authors:  Eric Murillo-Rodríguez
Journal:  Sleep Vigil       Date:  2021-09-25

7.  Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19.

Authors:  Tobias Zahn; Ines Mhedhbi; Sascha Hein; Jan Raupach; Csaba Miskey; Younes Husria; Kathrin Bayanga; Detlef Bartel; Stefan Vieths; Zoltan Ivics; Doris Oberle; Brigitte Keller-Stanislawski; Marie-Luise Herrlein; Thorsten Jürgen Maier; Eberhard Hildt
Journal:  Allergy       Date:  2021-10-24       Impact factor: 14.710

8.  Physiological Effects of Surgical and N95 Masks During Exercise in the COVID-19 era.

Authors:  Lili Shui; Binbin Yang; Hong Tang; Yan Luo; Shuang Hu; Xiaoqing Zhong; Jun Duan
Journal:  Am J Med Sci       Date:  2022-02-27       Impact factor: 3.462

9.  Environmental contamination with SARS-CoV-2 in COVID-19 hospitals in Wuhan, China, 2020.

Authors:  Wei Liu; Dingchen Li; Chaojie Yang; Fangyan Chen; Ruizhong Jia; Leili Jia; Xinyi Xia; Shanhong Fan; Qing Tan; Yuehua Ke; Yong Chen; Haifeng Li; Linfeng Zhan; Xiong Liu; Jianping You; Xiaolin Fu; Dan Li; Lin Zhang; Changjun Wang; Li Han
Journal:  Environ Microbiol       Date:  2021-08-16       Impact factor: 5.476

10.  Clinical Predictors of COVID-19 Mortality Among Patients in Intensive Care Units: A Retrospective Study.

Authors:  Abbas Al Mutair; Alya Al Mutairi; Abdul Rehman Zia Zaidi; Samer Salih; Saad Alhumaid; Ali A Rabaan; Awad Al-Omari
Journal:  Int J Gen Med       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.